Niacin Interactions

Adding cholesterol-dose niacin to atorvastatin raises the risk of muscle injury (myopathy, rarely rhabdomyolysis) without improving cardiovascular outcomes in patients already well treated with a statin.

Red yeast rice contains monacolin K, which is chemically identical to the statin lovastatin, so it behaves as a low-dose statin. Lipid-modifying amounts of niacin can independently injure skeletal muscle, and combining a lovastatin-class agent with such niacin can add to the risk of muscle pain or damage (including, rarely, rhabdomyolysis). Because red yeast rice acts as a variable-strength statin, the same additive muscle-toxicity concern applies when it is taken alongside high-dose niacin.

Niacin (vitamin B3) is the precursor to NAD+ and NADH, the electron carriers that feed Complex I of the mitochondrial electron transport chain, where CoQ10 shuttles those electrons onward toward ATP synthesis. They support adjacent steps of the same energy-producing pathway, making them a plausible mitochondrial-support pairing. The combination has not been tested head-to-head in humans, so the benefit is biologically reasonable rather than proven.

Niacin (nicotinic acid) is a vitamin B3 form the body converts to NAD+ through the Preiss-Handler pathway, so pairing low, vitamin-level niacin with a direct NAD+ precursor gives cells more than one biosynthetic route to build their NAD+ pool. Niacin has been shown to raise muscle and blood NAD+ in mitochondrial myopathy, though no human trial has tested combining it with direct NAD+, NR, or NMN — the synergy is plausible additive biology rather than a proven stack.

Niacin (vitamin B3) and the amino acid tryptophan are nutritionally linked: the body can make niacin from tryptophan through the kynurenine pathway, so the two together support the NAD/NADP coenzyme pools that power energy metabolism. Adequate niacin also frees up tryptophan for serotonin and melatonin production. This is a beneficial nutritional partnership, not a hazardous interaction.